Skip to main content
. 2013 Dec 14;4:8–13. doi: 10.1016/j.rinim.2013.11.002

Table 2.

Correlation between inflammatory biomarkers and patients characteristics.

IL-6 sgp130 sIL-6R CRP
Age 0.095, 0.002 0.05, 0.106 0.002, 0.953 0.032, 0.311
Systolic BPa 0.139, <0.001 0.081, 0.01 0.069, 0.028 -0.23, 0.458
TnT max 0.282, <0.001 0.06, 0.054 -0.051, 0.106 0.302, <0.001
NT-proBNP 0.217, <0.001 0.058, 0.066 -0.020, 0.535 0.328, <0.001
LVEFb -0.189, <0.001 -0.085, 0.018 0.018, 0.610 -0.274, <0.001
HbA1c 0.059, 0.065 0.092, 0.004 0.036, 0.264 0.064, 0.045
Admission glucose 0.058, 0.063 0.132, <0.001 0.032, 0.307 0.067, 0.032
Fasting glucose 0.124, <0.001 0.082, 0.009 0.028, 0.370 0.133, <0.001
Timec 0.077, 0.014 -0.049, 0.119 -0.109. <0.001 0.452, <0.001
IL-6 1 0.042, 0.176 0.007, 0.832 0.418, <0.001
sgp130 1 0.182, <0.001 -0.040, 0.205
sIL-6R 1 -0.103, 0.001
CRP 1

Data are presented as coefficients of correlation and p-values.

a

Systolic blood pressure.

b

Left ventricular ejection fraction.

c

Time interval from symptom onset to blood sampling in hours.

HHS Vulnerability Disclosure